Human pancreatic cancer cells may exhibit loss of responsiveness to TGF-β-mediated growth inhibition as a consequence of altered TGF-β expression as well as a result of postreceptor alterations [10]. This evidence concerns the gene TGFB1 and familial pancreatic carcinoma.